The stock of Teladoc Health Inc (TDOC) has gone up by 7.72% for the week, with a 19.15% rise in the past month and a -18.69% drop in the past quarter. The volatility ratio for the week is 5.31%, and the volatility levels for the past 30 days are 4.87% for TDOC. The simple moving average for the past 20 days is 11.31% for TDOC’s stock, with a -41.78% simple moving average for the past 200 days.
Is It Worth Investing in Teladoc Health Inc (NYSE: TDOC) Right Now?
TDOC has 36-month beta value of 0.88. Analysts have mixed views on the stock, with 6 analysts rating it as a “buy,” 4 as “overweight,” 3 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for TDOC is 168.59M, and currently, short sellers hold a 16.00% ratio of that float. The average trading volume of TDOC on September 16, 2024 was 6.82M shares.
TDOC) stock’s latest price update
Teladoc Health Inc (NYSE: TDOC)’s stock price has increased by 6.17 compared to its previous closing price of 7.62. However, the company has seen a 7.72% increase in its stock price over the last five trading sessions. seekingalpha.com reported 2024-09-15 that Teladoc’s stock fell ~97% from its peak, but recent changes, including a new CEO, present a high-risk, high-reward opportunity. Positive year-over-year trends in integrated care members and chronic care enrollment, but effective monetization of these members remains a challenge. However, Teladoc’s strong FCF and cheap valuation, trading at 4-5 times FCF, make it a potential turnaround candidate.
Analysts’ Opinion of TDOC
Many brokerage firms have already submitted their reports for TDOC stocks, with Cantor Fitzgerald repeating the rating for TDOC by listing it as a “Overweight.” The predicted price for TDOC in the upcoming period, according to Cantor Fitzgerald is $22 based on the research report published on February 29, 2024 of the current year 2024.
Leerink Partners, on the other hand, stated in their research note that they expect to see TDOC reach a price target of $17. The rating they have provided for TDOC stocks is “Market Perform” according to the report published on February 26th, 2024.
DA Davidson gave a rating of “Neutral” to TDOC, setting the target price at $22 in the report published on January 17th of the current year.
TDOC Trading at -0.50% from the 50-Day Moving Average
After a stumble in the market that brought TDOC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -64.11% of loss for the given period.
Volatility was left at 4.87%, however, over the last 30 days, the volatility rate increased by 5.31%, as shares surge +14.59% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -12.35% lower at present.
During the last 5 trading sessions, TDOC rose by +7.72%, which changed the moving average for the period of 200-days by -52.99% in comparison to the 20-day moving average, which settled at $7.32. In addition, Teladoc Health Inc saw -62.46% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at TDOC starting from MCKINLEY THOMAS, who purchase 4,000 shares at the price of $7.69 back on Sep 12 ’24. After this action, MCKINLEY THOMAS now owns 39,077 shares of Teladoc Health Inc, valued at $30,756 using the latest closing price.
Turitz Andrew, the EVP, CORPORATE DEVELOPMENT of Teladoc Health Inc, sale 20,773 shares at $7.26 during a trade that took place back on Sep 04 ’24, which means that Turitz Andrew is holding 20,773 shares at $150,812 based on the most recent closing price.
Stock Fundamentals for TDOC
Current profitability levels for the company are sitting at:
- -0.11 for the present operating margin
- 0.63 for the gross margin
The net margin for Teladoc Health Inc stands at -0.39. The total capital return value is set at -0.11. Equity return is now at value -52.96, with -25.65 for asset returns.
Based on Teladoc Health Inc (TDOC), the company’s capital structure generated 0.51 points at debt to capital in total, while cash flow to debt ratio is standing at 0.21. The debt to equity ratio resting at 1.03. The interest coverage ratio of the stock is -8.86.
Currently, EBITDA for the company is 192.05 million with net debt to EBITDA at -2.96. When we switch over and look at the enterprise to sales, we see a ratio of 0.69. The receivables turnover for the company is 11.35for trailing twelve months and the total asset turnover is 0.74. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.62.
Conclusion
To put it simply, Teladoc Health Inc (TDOC) has had a mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
